a strong trendgold
Infliximab treatment did not affect the MuSC count in the CTRL group, but in the OI‐treated group, it showed a strong trend towards an increased MuSC pool compared to OI VHL, although this did not reach statistical significance ( p = 0.057) (Figure 7B ).